Hui Z - Search Results

1

Design, synthesis and anti-tumor efficacy evaluation of novel 1,3-diaryl propane-based polyphenols obtained from Claisen rearrangement reaction.

Jiang SW, Qi X, Deng H, Gao Y, Yuan Y, Dang X, Xu B, Ma S, Xie T, Ye XY, Hui Z. Jiang SW, et al. Among authors: hui z. Bioorg Chem. 2023 Nov;140:106753. doi: 10.1016/j.bioorg.2023.106753. Epub 2023 Aug 4. Bioorg Chem. 2023. PMID: 37595397

2

Novel Selective Histone Deacetylase 6 (HDAC6) Inhibitors: A Patent Review (2016-2019).

He X, Li Z, Zhuo XT, Hui Z, Xie T, Ye XY. He X, et al. Among authors: hui z. Recent Pat Anticancer Drug Discov. 2020;15(1):32-48. doi: 10.2174/1574892815666200217125419. Recent Pat Anticancer Drug Discov. 2020. PMID: 32065106 Review.

3

4-Hydroxy-3-methylbenzofuran-2-carbohydrazones as novel LSD1 inhibitors.

He X, Gao Y, Hui Z, Shen G, Wang S, Xie T, Ye XY. He X, et al. Among authors: hui z. Bioorg Med Chem Lett. 2020 May 15;30(10):127109. doi: 10.1016/j.bmcl.2020.127109. Epub 2020 Mar 13. Bioorg Med Chem Lett. 2020. PMID: 32201021

4

Small molecule DNA-PK inhibitors as potential cancer therapy: a patent review (2010-present).

Hu S, Hui Z, Lirussi F, Garrido C, Ye XY, Xie T. Hu S, et al. Among authors: hui z. Expert Opin Ther Pat. 2021 May;31(5):435-452. doi: 10.1080/13543776.2021.1866540. Epub 2021 Feb 10. Expert Opin Ther Pat. 2021. PMID: 33347360 Review.

5

Medicinal chemistry updates of novel HDACs inhibitors (2020 to present).

He X, Hui Z, Xu L, Bai R, Gao Y, Wang Z, Xie T, Ye XY. He X, et al. Among authors: hui z. Eur J Med Chem. 2022 Jan 5;227:113946. doi: 10.1016/j.ejmech.2021.113946. Epub 2021 Oct 22. Eur J Med Chem. 2022. PMID: 34775332 Review.

6

Discovery of small-molecule ATR inhibitors for potential cancer treatment: a patent review from 2014 to present.

Hu S, Hui Z, Duan J, Garrido C, Xie T, Ye XY. Hu S, et al. Among authors: hui z. Expert Opin Ther Pat. 2022 Apr;32(4):401-421. doi: 10.1080/13543776.2022.2027911. Epub 2022 Feb 13. Expert Opin Ther Pat. 2022. PMID: 35001778

7

Second generation β-elemene nitric oxide derivatives with reasonable linkers: potential hybrids against malignant brain glioma.

Bai R, Zhu J, Bai Z, Mao Q, Zhang Y, Hui Z, Luo X, Ye XY, Xie T. Bai R, et al. Among authors: hui z. J Enzyme Inhib Med Chem. 2022 Dec;37(1):379-385. doi: 10.1080/14756366.2021.2016734. J Enzyme Inhib Med Chem. 2022. PMID: 35012394 Free PMC article.

8

Recent Advances in Synergistic Antitumor Effects Exploited from the Inhibition of Ataxia Telangiectasia and RAD3-Related Protein Kinase (ATR).

Wang LW, Jiang S, Yuan YH, Duan J, Mao ND, Hui Z, Bai R, Xie T, Ye XY. Wang LW, et al. Among authors: hui z. Molecules. 2022 Apr 12;27(8):2491. doi: 10.3390/molecules27082491. Molecules. 2022. PMID: 35458687 Free PMC article. Review.

9

Design, synthesis and antitumor efficacy evaluation of a series of novel β-elemene-based macrocycles.

Qi X, Jiang S, Hui Z, Gao Y, Ye Y, Lirussi F, Garrido C, Xu L, He X, Bai R, Ye XY, Xie T. Qi X, et al. Among authors: hui z. Bioorg Med Chem. 2022 Nov 15;74:117049. doi: 10.1016/j.bmc.2022.117049. Epub 2022 Oct 7. Bioorg Med Chem. 2022. PMID: 36240626

10

An updated patent review of protein arginine N-methyltransferase inhibitors (2019-2022).

Dong J, Duan J, Hui Z, Garrido C, Deng Z, Xie T, Ye XY. Dong J, et al. Among authors: hui z. Expert Opin Ther Pat. 2022 Dec;32(12):1185-1205. doi: 10.1080/13543776.2022.2163162. Epub 2023 Jan 3. Expert Opin Ther Pat. 2022. PMID: 36594709 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

619 results

Search Page

Filters